We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+23.65%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$798M
AUM Growth
+$39.2M
Cap. Flow
-$4.02M
Cap. Flow %
-0.5%
Top 10 Hldgs %
95.97%
Holding
24
New
4
Increased
6
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$6.38M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.23M
3
YMAB
Y-mAbs Therapeutics
YMAB
+$4.68M
4
BDSX icon
Biodesix
BDSX
+$3.67M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$2.35M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$8.01M
2
AGEN
Agenus
AGEN
+$4.85M
3
AXDX
Accelerate Diagnostics
AXDX
+$2.56M
4
OPK icon
Opko Health
OPK
+$770K
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3K

Sector Composition

Rank Sector Weight
1 Healthcare 99.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$316M 39.61%
1,759,421
-36,041
-2% -$8.01M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$184M 23.07%
2,148,271
+73,471
+4% +$6.23M
AWH
3
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$58M 7.27%
576,473
-45
-0% -$3K
OPK icon
4
Opko Health
OPK
$1.25B
$52M 6.52%
13,171,273
-184,500
-1% -$770K
PACB icon
5
Pacific Biosciences
PACB
$432M
$44.7M 5.6%
1,721,459
– –
AGEN
6
Agenus
AGEN
$275M
$37.7M 4.72%
603,878
-65,345
-10% -$4.85M
AXDX
7
DELISTED
Accelerate Diagnostics
AXDX
$28.9M 3.62%
380,614
-28,561
-7% -$2.56M
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.48B
$22.2M 2.78%
2,980,870
+455,013
+18% +$2.35M
DMTK
9
DELISTED
DermTech, Inc. Common Stock
DMTK
$14.6M 1.83%
+450,000
New +$6.38M
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
$7.58M 0.95%
1,900,000
+200,434
+12% +$648K
SLNO
11
DELISTED
Soleno Therapeutics
SLNO
$7.08M 0.89%
244,692
– –
YMAB
12
DELISTED
Y-mAbs Therapeutics
YMAB
$6.25M 0.78%
126,342
+101,130
+401% +$4.68M
AMRN
13
Amarin Corp
AMRN
$293M
$5.05M 0.63%
51,639
+864
+2% +$83.3K
BDSX icon
14
Biodesix
BDSX
$218M
$4.19M 0.53%
+11,776
New +$3.67M
MOTS
15
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$3.61M 0.45%
12,689
– –
TBIO
16
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1.84M 0.23%
+100,000
New +$1.79M
QDEL icon
17
CALL
QuidelOrtho
QDEL
$1.14B
$1.08M 0.14%
119,700
-108,300
-48% -$24.1M
BIIB icon
18
Biogen
BIIB
$30.4B
$903K 0.11%
3,688
– –
CFRX
19
DELISTED
ContraFect Corporation
CFRX
$846K 0.11%
2,095
– –
BIOL
20
DELISTED
Biolase, Inc.
BIOL
$725K 0.09%
696
– –
BHVN
21
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$400K 0.05%
100,000
+31,900
+47% +$2.7M
WBA
22
CALL
DELISTED
Walgreens Boots Alliance
WBA
$203K 0.03%
+200,400
New +$7.76M
AGEN
23
CALL
Agenus
AGEN
$275M
– –
-5,360
Closed -$39K
AMRN
24
CALL
Amarin Corp
AMRN
$293M
– –
-15,265
Closed -$8K

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Oracle Investment Management held 24 positions worth $798M, up 5.2% from $759M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Oracle Investment Management's Q4 2020 filing shows 4 new, 6 increased, 6 reduced and 2 closed positions. Its largest new stake was DermTech, Inc. Common Stock: 450,000 shares worth $14.6M. The largest sale was QuidelOrtho, an estimated $8.01M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Oracle Investment Management's largest Q4 2020 buy was DermTech, Inc. Common Stock: 450,000 shares worth $14.6M.
  • Oracle Investment Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, an estimated $6.23M increase.
  • Oracle Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $8.01M.
  • Oracle Investment Management's ten largest holdings make up 96% of its $798M portfolio in Q4 2020.
  • Oracle Investment Management opened 4 new positions and closed 2 in Q4 2020.
  • Oracle Investment Management's portfolio value rose 5.2% quarter-over-quarter to $798M.

Based on Oracle Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.